PATENT CLAIM ANALYSIS

Application Number: 16070220
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-08
Patent Classification: ["424", "184100"]

Abstract:
The present invention relates to an immunomodulator for the prevention or treatment of an allergic disease caused by house dust mite-derived allergens. Particularly, the present invention provides an immunomodulatory pharmaceutical composition comprising as an effective ingredient a bacteria extracellular vesicle containing an allergens derived from North American house dust mite or European house dust mite, and a preparation method therefor.

Claim (Index 15):
The method of  claim 12 , wherein the at least one mite allergen comprises one or more allergens selected from the group consisting of Der p1, Der p2, Der p3, Der p4, Der p6, Der p9, and Der p15 of European house dust mite (Dermatophagoidespteronyssinus).

Metadata:
- Claim Count in Document: 26.0
- Percentile: 95.0
- Lexical Diversity: 1.3617
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13499653', '09513645', '13314024', '12934418', '12572599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7395079105908008
- 35 USC 102 Novelty (BERT): 0.5177728933936842
- Combined Prediction Score: 0.7173344088710891
- Mean Citation Score: 285.39262800000006
- Max Citation Score: 297.10016
- Similarity Product: 177.73876338615418

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test